Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Paratek Pharmaceuticals Q1 EPS $(0.35) Misses $(0.33) Estimate, Sales $31.24M Miss $33.77M Estimate

Author: Benzinga Newsdesk | May 09, 2023 04:15pm
Paratek Pharmaceuticals (NASDAQ:PRTK) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.33) by 6.06 percent. This is unchanged from the same period last year. The company reported quarterly sales of $31.24 million which missed the analyst consensus estimate of $33.77 million by 7.50 percent. This is a 25.64 percent increase over sales of $24.86 million the same period last year.

Posted In: PRTK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist